Shanxi Eye Hospital Affiliated to Shanxi Medical University, Taiyuan 030002, China.
Shanxi Eye Hospital Affiliated to Shanxi Medical University, Taiyuan 030002, China; Translational Medicine Research Center, Shanxi Medical University, Taiyuan 030001, China.
Int Immunopharmacol. 2024 Dec 25;143(Pt 1):113138. doi: 10.1016/j.intimp.2024.113138. Epub 2024 Oct 2.
High myopia (HM) is characterized by a significant extension of the eye axis; it has emerged as a serious global public health issue recently. In addition to causing severe visual impairment, HM is associated with several problems that may compromise an individual's vision. Although genetic and environmental factors in HM have been extensively investigated, increasing evidence implicates the immune system and its microenvironment in its pathogenesis. In this review, we explore the complex interactions between cytokines, immune cells, and the eye environment to elucidate the complex processes controlling the immune response in HM. Furthermore, we investigated treatments modulating the immune response and alleviating the progression of HM and its complications. Through a review of the current relevant studies, we highlight the critical functions of the immune system in the multifactorial development of HM. With the evolving understanding of the immune system's involvement in HM, this review provides a valuable resource to clinicians and researchers to develop targeted interventions and personalized treatments for individuals with this vision-threatening condition.
高度近视(HM)的特征是眼轴显著延长;最近,它已成为一个严重的全球公共卫生问题。除了导致严重的视力损害外,HM 还与可能损害个体视力的几种问题有关。尽管 HM 中的遗传和环境因素已被广泛研究,但越来越多的证据表明免疫系统及其微环境在其发病机制中起作用。在这篇综述中,我们探讨了细胞因子、免疫细胞和眼睛环境之间的复杂相互作用,以阐明控制 HM 中免疫反应的复杂过程。此外,我们还研究了调节免疫反应并缓解 HM 及其并发症进展的治疗方法。通过对当前相关研究的回顾,我们强调了免疫系统在 HM 的多因素发展中的关键作用。随着对免疫系统在 HM 中参与的不断理解,本综述为临床医生和研究人员提供了有价值的资源,以针对这种威胁视力的疾病开发靶向干预和个性化治疗。